To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene SNAI2TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
254 supporting clones for gene SNAI2 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
N35661 melanocyte .a 1 to 306 1 to 305   tiling clone,   305/305
(100 %)
3 diff
(99.1 %id)
BX394762 Neuroblastoma Cot 25-normalized .a 67 to 939 1 to 875   tiling clone,   875/875
(100 %)
3 diff
(99.7 %id)
DA599165   .a 154 to 713 2 to 561   capped   560/560
(100 %)
1 diff
(99.9 %id)
DA066566 cerebellum .a 155 to 716 2 to 563   capped   562/562
(100 %)
4 diff
(99.3 %id)
DA522147 brain .a 155 to 724 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
DA601187   .a 156 to 726 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
BP221936   .a 159 to 732 8 to 581       574/574
(100 %)
0 diff
(100 %id)
BG706203 brain, hypothalamus .a 161 to 855 1 to 694       694/694
(100 %)
5 diff
(99.3 %id)
BI601834 brain, hypothalamus .a 161 to 981 1 to 820       820/820
(100 %)
10 diff
(98.8 %id)
TI_45210353   .a 162 to 981 83 to 901       819/901
(90 %)
13 diff
(98.6 %id)
AK223368 dermoid cancer .a 166 to 2171 1 to 2006 E126K AAA   2006/2006
(100 %)
1 diff
(100.0 %id)
AK312661   .a 166 to 1136 1 to 971 exact     971/971
(100 %)
0 diff
(100 %id)
CD616196   .a 166 to 872 31 to 737       707/737
(95 %)
8 diff
(99.0 %id)
CD616199   .a 166 to 624 31 to 489       459/489
(93 %)
6 diff
(98.8 %id)
CD616203   .a 166 to 876 31 to 743       713/743
(95 %)
9 diff
(98.8 %id)
CD616207   .a 166 to 868 29 to 721       693/721
(96 %)
21 diff
(97.1 %id)
BP227685   .a 166 to 746 1 to 581       581/581
(100 %)
1 diff
(99.9 %id)
DA653011   .a 166 to 710 2 to 546   capped   545/545
(100 %)
0 diff
(100 %id)
AU280284   .a 166 to 731 1 to 566       566/566
(100 %)
0 diff
(100 %id)
NM_003068.3   .a 166 to 2266 1 to 2101 exact RefSeq,   2101/2101
(100 %)
0 diff
(100 %id)
DA844349 placenta .a 166 to 635 2 to 471   capped   470/470
(100 %)
0 diff
(100 %id)
DA009941 adrenal gland .a 167 to 724 2 to 560   capped   559/559
(100 %)
1 diff
(99.9 %id)
DA020668   .a 167 to 740 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
DA130743 alzheimer cortex .a 167 to 734 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
DA250817 caudate nucleus .a 167 to 732 2 to 568   capped   567/567
(100 %)
1 diff
(99.9 %id)
DA353350 substantia nigra .a 167 to 746 2 to 581   capped   580/580
(100 %)
0 diff
(100 %id)
DA372032 thalamus .a 167 to 713 2 to 548   capped   547/548
(99 %)
1 diff
(99.9 %id)
DA378361 thalamus .a 167 to 735 2 to 570   capped   569/569
(100 %)
1 diff
(99.9 %id)
DA421131 cervix .a 167 to 501 2 to 336   capped   335/335
(100 %)
0 diff
(100 %id)
DA422116 cervix .a 167 to 737 2 to 574   capped   573/573
(100 %)
2 diff
(99.7 %id)
DA422733 cervix .a 167 to 726 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
DA423319   .a 167 to 635 2 to 470   capped   469/469
(100 %)
0 diff
(100 %id)
DA423322   .a 167 to 689 2 to 524   capped   523/523
(100 %)
1 diff
(99.9 %id)
DA424415   .a 167 to 719 2 to 554   capped   553/553
(100 %)
0 diff
(100 %id)
DA473964   .a 167 to 735 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
DA480367   .a 167 to 713 2 to 548   capped   547/547
(100 %)
2 diff
(99.7 %id)
DA537966 Kidney .a 167 to 765 2 to 600   capped   599/599
(100 %)
0 diff
(100 %id)
DA546232   .a 167 to 731 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
DA556379   .a 167 to 741 2 to 576   capped   575/576
(99 %)
1 diff
(99.9 %id)
DA567676   .a 167 to 712 2 to 547   capped   546/546
(100 %)
1 diff
(99.9 %id)
DA575087   .a 167 to 747 2 to 582   capped   581/581
(100 %)
0 diff
(100 %id)
DA580177   .a 167 to 732 2 to 567   capped   566/566
(100 %)
1 diff
(99.9 %id)
DA652883   .a 167 to 691 2 to 526   capped   525/525
(100 %)
0 diff
(100 %id)
DA654739   .a 167 to 735 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
DA657046   .a 167 to 472 2 to 307   capped   306/306
(100 %)
0 diff
(100 %id)
DA660022   .a 167 to 736 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
DA664685   .a 167 to 711 2 to 546   capped   545/545
(100 %)
0 diff
(100 %id)
DA683736   .a 167 to 696 2 to 531   capped   530/530
(100 %)
2 diff
(99.7 %id)
DA707753   .a 167 to 746 2 to 581   capped   580/580
(100 %)
0 diff
(100 %id)
DA714047   .a 167 to 735 2 to 573   capped   572/572
(100 %)
4 diff
(99.4 %id)
DA764242 tongue .a 167 to 754 2 to 589   capped   588/588
(100 %)
0 diff
(100 %id)
DA825045 pericardium .a 167 to 746 2 to 586   capped   585/585
(100 %)
5 diff
(99.2 %id)
DA916846 small intestine .a 167 to 708 2 to 543   capped   542/542
(100 %)
0 diff
(100 %id)
DA930233 small intestine .a 167 to 775 2 to 610   capped   609/609
(100 %)
1 diff
(99.9 %id)
DA997048   .a 167 to 635 2 to 470   capped   469/469
(100 %)
0 diff
(100 %id)
DB001690 breast, tumor tissue .a 167 to 689 2 to 524   capped   523/523
(100 %)
1 diff
(99.9 %id)
DN992307 brain, whole brain .a 167 to 793 1 to 627       627/627
(100 %)
5 diff
(99.3 %id)
DB017663 esophageal, tumor tissue .a 167 to 729 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
DB247818 uterus .a 167 to 726 2 to 565   capped   564/564
(100 %)
4 diff
(99.3 %id)
DB250089 uterus .a 167 to 724 2 to 559   capped   558/559
(99 %)
1 diff
(99.9 %id)
DB251274 uterus .a 167 to 728 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
DB251712 uterus .a 167 to 700 2 to 535   capped   534/534
(100 %)
0 diff
(100 %id)
DB252812 uterus .a 167 to 742 2 to 577   capped   576/576
(100 %)
0 diff
(100 %id)
DB253078 uterus .a 167 to 738 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
DB257365 uterus .a 167 to 744 2 to 579   capped   578/578
(100 %)
1 diff
(99.9 %id)
DB258386 uterus .a 167 to 731 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
DB262442 uterus .a 167 to 734 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
DB272984 uterus .a 167 to 720 2 to 555   capped   554/554
(100 %)
1 diff
(99.9 %id)
CR611662 Placenta Cot 25-normalized .a 169 to 2141 1 to 1973 exact     1973/1973
(100 %)
0 diff
(100 %id)
BX359236 Placenta Cot 25-normalized .a 169 to 1152 1 to 975 E210G K211E P212A S214F C215L ... fully sequenced,   975/975
(100 %)
4 diff
(99.6 %id)
DB247479 uterus .a 169 to 735 2 to 568   capped   567/567
(100 %)
1 diff
(99.9 %id)
DA013017 adrenal gland .a 171 to 760 2 to 591   capped   590/590
(100 %)
0 diff
(100 %id)
BJ990016 hepatoblastoma .a 171 to 753 1 to 583       583/583
(100 %)
0 diff
(100 %id)
DB258795 uterus .a 171 to 746 2 to 577   capped   576/576
(100 %)
2 diff
(99.7 %id)
BP289540 lung .a 173 to 752 1 to 580       580/580
(100 %)
0 diff
(100 %id)
BP291096 lung .a 173 to 756 1 to 584       584/584
(100 %)
0 diff
(100 %id)
BC014890 Uterus, leiomyosarcoma .a 178 to 2171 1 to 1994 exact tiling clone, available from MGC, AAA   1994/1994
(100 %)
0 diff
(100 %id)
BM461800 leiomyosarcoma, uterus .a 178 to 1026 1 to 859       859/914
(93 %)
14 diff
(98.5 %id)
CR616026 Neuroblastoma Cot 25-normalized .a 182 to 2151 1 to 1970 exact     1970/1970
(100 %)
0 diff
(100 %id)
BX375783 Neuroblastoma Cot 25-normalized .a 182 to 1160 1 to 978 I28N I29Y S30F Y32V L33S ... fully sequenced,   978/978
(100 %)
10 diff
(99.0 %id)
BX338439 Placenta Cot 25-normalized .a 182 to 1208 1 to 1023 P88S K162X E210G K211E P212A ...     1023/1029
(99 %)
24 diff
(97.7 %id)
CR608999 Placenta Cot 25-normalized .a 183 to 2150 1 to 1968 exact     1968/1968
(100 %)
0 diff
(100 %id)
BX334341 Placenta Cot 25-normalized .a 183 to 1155 1 to 964 E261X A267D H268T fully sequenced,   964/964
(100 %)
1 diff
(99.9 %id)
BX357616 Placenta Cot 25-normalized .a 183 to 1122 1 to 933       933/933
(100 %)
10 diff
(99.0 %id)
BG681502 skin, squamous cell carcinoma .a 183 to 1013 1 to 832       832/832
(100 %)
7 diff
(99.2 %id)
DA569567 whole embryo, mainly head .a 187 to 952 2 to 773   capped   772/772
(100 %)
9 diff
(98.9 %id)
BC015895 Uterus, leiomyosarcoma .a 198 to 2171 1 to 1974 exact available from MGC, AAA   1974/1974
(100 %)
0 diff
(100 %id)
CR610096 Placenta Cot 25-normalized .a 199 to 2142 1 to 1944 exact     1944/1944
(100 %)
0 diff
(100 %id)
AL544692 placenta, Placenta Cot 25-normalized .a 211 to 1082 1 to 872       872/872
(100 %)
0 diff
(100 %id)
BX382381 Placenta Cot 25-normalized .a 221 to 1167 22 to 958 A267H H268T fully sequenced,   937/958
(97 %)
10 diff
(99.0 %id)
TI_1948102261   .a 330 to 591 129 to 390       262/291
(90 %)
6 diff
(98.0 %id)
TI_1948102600   .a 330 to 523 127 to 320   fully sequenced,   194/222
(87 %)
6 diff
(97.3 %id)
TI_1948102759   .a 330 to 582 128 to 380       253/280
(90 %)
6 diff
(97.9 %id)
TI_1948102428   .a 332 to 1141 127 to 934   fully sequenced,   808/934
(86 %)
67 diff
(92.9 %id)
CR605323 Placenta Cot 25-normalized .a 353 to 1457 1 to 1105       1105/1105
(100 %)
0 diff
(100 %id)
BX340348 Placenta Cot 25-normalized .a 353 to 1337 1 to 974       974/974
(100 %)
19 diff
(98.1 %id)
BX386499 Placenta Cot 25-normalized .a 353 to 1296 1 to 945       945/947
(99 %)
12 diff
(98.8 %id)
BX387293 Placenta Cot 25-normalized .a 353 to 1238 1 to 874       874/877
(99 %)
40 diff
(95.5 %id)
BG576405 breast, mammary adenocarcinoma, cell line .a 373 to 1103 1 to 733       733/1127
(65 %)
5 diff
(99.6 %id)
N91754 liver and spleen .a 380 to 510 13 to 143       131/145
(90 %)
7 diff
(95.2 %id)
TI_57186208   .a 403 to 1238 56 to 888   AAA   833/865
(96 %)
12 diff
(98.7 %id)
BE884167 leiomyosarcoma, uterus .a 404 to 1108 1 to 703       703/800
(87 %)
26 diff
(96.8 %id)
BI855918 breast, mammary adenocarcinoma, cell line .a 405 to 1238 1 to 831       831/871
(95 %)
9 diff
(99.0 %id)
BP291551 lung .a 423 to 1007 1 to 585       585/585
(100 %)
9 diff
(98.5 %id)
ES314644 occipital scalp hair, skin .a 436 to 588 1 to 153       153/153
(100 %)
0 diff
(100 %id)
BF736046 bladder_tumor .a 456 to 1013 623 to 66     Submitted on the opposite strand 558/623
(89 %)
6 diff
(99.1 %id)
BF570863 melanotic melanoma, high MDR, skin .a 484 to 1177 1 to 697       697/887
(78 %)
52 diff
(94.2 %id)
BF840504 head_neck .a 490 to 859 1 to 370       370/370
(100 %)
10 diff
(97.3 %id)
TI_1948102601   .a 493 to 1141 768 to 120   fully sequenced,   649/768
(84 %)
0 diff
(100 %id)
BI258890 cervical carcinoma cell line, cervix .a 598 to 1552 1 to 955       955/959
(99 %)
28 diff
(97.1 %id)
CD616204   .a 628 to 1265 5 to 642       638/642
(99 %)
6 diff
(99.1 %id)
BU506877 leiomyosarcoma, uterus .a 633 to 1536 1 to 906       906/909
(99 %)
9 diff
(99.1 %id)
BF979194 melanotic melanoma, high MDR, skin .a 653 to 1370 1 to 708       708/857
(82 %)
17 diff
(98.1 %id)
BF977984 melanotic melanoma, high MDR, skin .a 653 to 1237 1 to 590       590/929
(63 %)
8 diff
(99.2 %id)
AW368351 head_neck .a 657 to 1287 1 to 632       632/632
(100 %)
16 diff
(97.5 %id)
N40616 melanocyte .a 660 to 1036 1 to 379       379/383
(98 %)
3 diff
(99.3 %id)
U69196 whole brain .a 675 to 2172 1 to 1498       1498/1498
(100 %)
3 diff
(99.8 %id)
CN402435 embryonic stem cells, cell lines H1, H7, andH9 .a 686 to 1236 1 to 550       550/550
(100 %)
1 diff
(99.9 %id)
R95170 liver and spleen .a 687 to 1142 1 to 461       461/463
(99 %)
19 diff
(95.9 %id)
BX097493 liver and spleen .a 694 to 1505 1 to 812       812/812
(100 %)
0 diff
(100 %id)
H57309 liver and spleen .a 694 to 1113 1 to 434       434/439
(98 %)
18 diff
(95.9 %id)
N23505 melanocyte .a 705 to 1212 1 to 518       518/518
(100 %)
10 diff
(98.1 %id)
CN402438 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 738 to 1447 1 to 710       710/710
(100 %)
3 diff
(99.6 %id)
CB216401 normal endometrium, mid-secretory phase,cycle day 23, uterus .a 756 to 1377 1 to 622       622/622
(100 %)
3 diff
(99.6 %id)
BM542662 leiomyosarcoma, uterus .a 798 to 1767 1 to 973       973/975
(99 %)
25 diff
(97.5 %id)
BE885066 leiomyosarcoma, uterus .a 817 to 1508 1 to 684       684/872
(78 %)
21 diff
(97.6 %id)
R24694 placenta .a 834 to 1154 1 to 327       327/400
(81 %)
8 diff
(98.0 %id)
BF218546 brain, glioblastoma .a 851 to 1411 1 to 565       565/813
(69 %)
15 diff
(98.2 %id)
TI_1948102760   .a 859 to 1141 401 to 119       283/304
(93 %)
0 diff
(100 %id)
FN074430 breast carcinoma .a 864 to 952 87 to 1     Submitted on the opposite strand 87/88
(98 %)
2 diff
(97.8 %id)
N44095 melanocyte .a 892 to 1164 1 to 275       275/277
(99 %)
4 diff
(98.6 %id)
TI_1948102429   .a 894 to 1141 306 to 59   fully sequenced,   248/269
(92 %)
0 diff
(100 %id)
BU161260 melanotic melanoma, skin .a 907 to 1696 1 to 794   AAA   794/794
(100 %)
11 diff
(98.7 %id)
TI_1948102262   .a 914 to 1141 345 to 118       228/249
(91 %)
0 diff
(100 %id)
W02279 melanocyte .a 929 to 1133 1 to 205       205/205
(100 %)
0 diff
(100 %id)
H77866 liver and spleen .a 936 to 1290 1 to 357       357/361
(98 %)
5 diff
(98.7 %id)
BF240865 bone marrow, from acute myelogenous leukemia .a 949 to 1650 1 to 710       710/791
(89 %)
42 diff
(94.7 %id)
BG679875 skin, squamous cell carcinoma .a 953 to 1740 1 to 791       791/820
(96 %)
13 diff
(98.5 %id)
BI061392 uterus_tumor .a 954 to 1624 696 to 28       669/702
(95 %)
0 diff
(100 %id)
N36731 melanocyte .a 957 to 1294 1 to 338       338/338
(100 %)
2 diff
(99.5 %id)
W07724 lung .a 1021 to 1539 1 to 525       525/525
(100 %)
7 diff
(98.7 %id)
BX340347 Placenta Cot 25-normalized .a 1040 to 2128 1078 to 1       1078/1078
(100 %)
39 diff
(96.4 %id)
BG571739 placenta .a 1090 to 1759 1 to 673       673/708
(95 %)
17 diff
(97.6 %id)
BX370119 Placenta Cot 25-normalized .a 1102 to 1740 1 to 640       640/644
(99 %)
2 diff
(99.7 %id)
BX390547 Placenta Cot 25-normalized .a 1102 to 1741 1 to 639       639/644
(99 %)
8 diff
(98.8 %id)
BE881619 large cell carcinoma, undifferentiated, lung .a 1102 to 1799 1 to 694       694/965
(71 %)
14 diff
(98.6 %id)
BX390548 Placenta Cot 25-normalized .a 1107 to 1736 1 to 631       631/640
(98 %)
14 diff
(97.9 %id)
BX334340 Placenta Cot 25-normalized .a 1125 to 2150 1019 to 1   fully sequenced,   1019/1019
(100 %)
5 diff
(99.6 %id)
BG574610 breast, mammary adenocarcinoma, cell line .a 1127 to 1953 1 to 829       829/955
(86 %)
7 diff
(99.3 %id)
BX338087 Placenta Cot 25-normalized .a 1129 to 2141 1012 to 1   fully sequenced,   1012/1012
(100 %)
22 diff
(97.9 %id)
BX365419 Placenta Cot 25-normalized .a 1129 to 2107 979 to 1       979/979
(100 %)
4 diff
(99.6 %id)
BX375782 Neuroblastoma Cot 25-normalized .a 1130 to 2151 1018 to 1   fully sequenced,   1018/1018
(100 %)
15 diff
(98.6 %id)
EL951502 eyeball .a 1131 to 1641 24 to 533       510/533
(95 %)
6 diff
(98.9 %id)
BI061519 uterus_tumor .a 1135 to 1618 482 to 1       482/482
(100 %)
1 diff
(99.8 %id)
BX361065 Placenta Cot 25-normalized .a 1137 to 2142 980 to 1   fully sequenced,   980/980
(100 %)
13 diff
(98.7 %id)
BX357615 Placenta Cot 25-normalized .a 1158 to 2139 984 to 1       984/984
(100 %)
5 diff
(99.5 %id)
CA453704 mixed (pool of 40 RNAs) .a 1165 to 1936 1 to 778       778/780
(99 %)
13 diff
(98.4 %id)
AA665321   .a 1201 to 1447 251 to 5       247/251
(98 %)
0 diff
(100 %id)
BX376053 Neuroblastoma Cot 25-normalized .a 1214 to 2141 932 to 1       932/932
(100 %)
41 diff
(95.7 %id)
AL544652 placenta, Placenta Cot 25-normalized .a 1226 to 2140 914 to 1       914/914
(100 %)
10 diff
(99.0 %id)
CN292532 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 1239 to 1370 1 to 132       132/132
(100 %)
0 diff
(100 %id)
N28287 melanocyte .a 1240 to 1767 1 to 537   fully sequenced,   537/537
(100 %)
19 diff
(96.5 %id)
BG250221 adenocarcinoma, cell line, Liver .a 1242 to 1985 1 to 728       728/875
(83 %)
13 diff
(98.6 %id)
BM927991 brain .a 1242 to 2158 1 to 936       936/1129
(82 %)
38 diff
(96.7 %id)
TI_149293792   .a 1255 to 2171 995 to 80   AAA   916/1013
(90 %)
12 diff
(98.9 %id)
TI_149285024   .a 1274 to 2259 1056 to 82   AAA   975/1145
(85 %)
38 diff
(96.7 %id)
BG540794 lung .a 1286 to 1993 1 to 704       704/904
(77 %)
34 diff
(96.3 %id)
H98781 melanocyte .a 1293 to 1687 403 to 8       396/403
(98 %)
0 diff
(100 %id)
CD616197   .a 1296 to 1604 329 to 21       309/333
(92 %)
0 diff
(100 %id)
CD616198   .a 1296 to 1604 329 to 21       309/333
(92 %)
0 diff
(100 %id)
CD616200   .a 1296 to 1604 328 to 21       308/332
(92 %)
0 diff
(100 %id)
CD616202   .a 1296 to 1604 327 to 20       308/331
(93 %)
0 diff
(100 %id)
CD616206   .a 1296 to 1604 328 to 20       309/332
(93 %)
0 diff
(100 %id)
AA249555   .a 1299 to 1437 1 to 137       137/137
(100 %)
2 diff
(98.6 %id)
AJ709827 heart .a 1326 to 1838 1 to 513       513/513
(100 %)
0 diff
(100 %id)
TI_149298052   .a 1354 to 2171 891 to 84   AAA   808/941
(85 %)
15 diff
(98.5 %id)
BF244896 brain, glioblastoma .a 1366 to 2020 1 to 656       656/825
(79 %)
20 diff
(97.6 %id)
BG288274 bladder, transitional cell papilloma, cell line .a 1377 to 2131 1 to 743       743/745
(99 %)
15 diff
(98.0 %id)
CA421450 Chondrosarcoma Grade II, Left Pelvis .a 1380 to 2171 807 to 19   AAA   789/789
(100 %)
5 diff
(99.4 %id)
AA406432 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 1401 to 1823 1 to 423       423/423
(100 %)
2 diff
(99.6 %id)
N64741 liver and spleen .a 1405 to 1843 459 to 1       459/459
(100 %)
30 diff
(93.5 %id)
BF378431 uterus .a 1409 to 1934 532 to 3       530/532
(99 %)
0 diff
(100 %id)
BE878487 large cell carcinoma, undifferentiated, lung .a 1411 to 2112 1 to 680       680/788
(86 %)
28 diff
(96.5 %id)
BU682810 lung .a 1420 to 2171 769 to 19   AAA   751/751
(100 %)
3 diff
(99.7 %id)
BF687581 brain, glioblastoma .a 1421 to 2090 1 to 651       651/829
(78 %)
33 diff
(96.1 %id)
W24395 lung .a 1431 to 1701 1 to 272       272/272
(100 %)
4 diff
(98.6 %id)
H57310 liver and spleen .a 1443 to 1843 414 to 1       414/423
(97 %)
19 diff
(95.6 %id)
BM983020 lung, Primary Lung Cystic Fibrosis EpithelialCells .a 1458 to 2171 731 to 19   AAA   713/713
(100 %)
1 diff
(99.9 %id)
H77822 liver and spleen .a 1464 to 1841 396 to 1       396/396
(100 %)
20 diff
(95.0 %id)
BQ354944 head_neck .a 1473 to 1886 429 to 16       414/432
(95 %)
0 diff
(100 %id)
CA413676 Chondrosarcoma Grade II, Left Pelvis .a 1482 to 2171 708 to 19   AAA   690/690
(100 %)
0 diff
(100 %id)
AA379403 skin .a 1489 to 1743 1 to 255       255/258
(98 %)
2 diff
(99.3 %id)
AW963929   .a 1490 to 2052 1 to 565       565/569
(99 %)
17 diff
(97.1 %id)
CA432427 cell lines, Chondrosarcoma .a 1492 to 2171 698 to 19   AAA   680/680
(100 %)
0 diff
(100 %id)
FN084675 breast carcinoma .a 1507 to 1585 82 to 2     Submitted on the opposite strand 81/82
(98 %)
0 diff
(100 %id)
BU619336 cell lines, Chondrosarcoma .a 1511 to 2171 676 to 19   AAA   658/662
(99 %)
5 diff
(99.3 %id)
BM991955 Bone, Subchondral Bone .a 1517 to 2171 672 to 19   AAA   654/654
(100 %)
2 diff
(99.7 %id)
CA440491 Chondrosarcoma, Left Pubic Bone .a 1518 to 2171 671 to 19   AAA   653/653
(100 %)
4 diff
(99.4 %id)
AI572079 adenocarcinoma, Pancreas .a 1533 to 2175 642 to 1       642/642
(100 %)
16 diff
(97.6 %id)
CD616205   .a 1537 to 2178 657 to 14       644/657
(98 %)
0 diff
(100 %id)
FN164646 breast carcinoma .a 1549 to 1653 107 to 1     Submitted on the opposite strand 107/122
(87 %)
4 diff
(96.8 %id)
AI339793 adenocarcinoma, colon .a 1593 to 2056 464 to 1       464/464
(100 %)
0 diff
(100 %id)
EH328076   .a 1609 to 1668 1 to 60       60/60
(100 %)
0 diff
(100 %id)
DW421038 Liver .a 1611 to 1892 17 to 298       282/298
(94 %)
6 diff
(98.0 %id)
DW452108 Liver .a 1611 to 1965 17 to 371       355/371
(95 %)
6 diff
(98.4 %id)
DB356220 whole embryo, mainly head .a 1618 to 2171 547 to 1       547/562
(97 %)
14 diff
(97.6 %id)
CN402432 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 1624 to 2170 8 to 554       547/554
(98 %)
6 diff
(99.0 %id)
AI814370 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .a 1645 to 2170 526 to 1       526/526
(100 %)
0 diff
(100 %id)
AI857578 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .a 1645 to 2172 529 to 1       529/529
(100 %)
2 diff
(99.7 %id)
AW006242 pooled germ cell tumors .a 1645 to 2173 529 to 1       529/529
(100 %)
1 diff
(99.9 %id)
BM984666 lung .a 1646 to 2259 629 to 16   AAA   614/614
(100 %)
1 diff
(99.9 %id)
BG939347 bone marrow stroma .a 1649 to 2171 553 to 31   AAA   523/523
(100 %)
1 diff
(99.9 %id)
BG620323 placenta .a 1662 to 2171 1 to 509   AAA   509/509
(100 %)
7 diff
(98.7 %id)
DB342348 thymus .a 1664 to 2171 508 to 1       508/508
(100 %)
2 diff
(99.7 %id)
AI580168 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 1676 to 2175 505 to 6       500/505
(99 %)
0 diff
(100 %id)
N36091 melanocyte .a 1679 to 2171 495 to 1       495/495
(100 %)
4 diff
(99.2 %id)
BQ022440 placenta .a 1689 to 2171 500 to 18   AAA   483/483
(100 %)
5 diff
(99.0 %id)
BQ019920 Chondrosarcoma, Left Pubic Bone .a 1694 to 2171 496 to 19   AAA   478/478
(100 %)
0 diff
(100 %id)
AI433692 Kidney .a 1707 to 2175 472 to 3       470/472
(99 %)
0 diff
(100 %id)
AI470820 Kidney .a 1707 to 2053 347 to 1       347/347
(100 %)
0 diff
(100 %id)
AI635365 pooled germ cell tumors .a 1712 to 2173 462 to 1       462/462
(100 %)
0 diff
(100 %id)
BF222729 pooled germ cell tumors .a 1712 to 2173 462 to 1       462/462
(100 %)
0 diff
(100 %id)
BF594335 colon, colon tumor, RER+ .a 1713 to 2171 470 to 12   AAA   459/459
(100 %)
1 diff
(99.8 %id)
AW304896 brain, three pooled meningiomas .a 1715 to 2173 459 to 1       459/459
(100 %)
3 diff
(99.4 %id)
AI375378   .a 1718 to 2174 457 to 1       457/457
(100 %)
0 diff
(100 %id)
AI380262 B-cell, chronic lymphotic leukemia .a 1718 to 2175 458 to 1       458/458
(100 %)
0 diff
(100 %id)
N36171 melanocyte .a 1720 to 2171 456 to 1       456/456
(100 %)
7 diff
(98.5 %id)
AI802389   .a 1722 to 2175 459 to 6       454/459
(98 %)
0 diff
(100 %id)
N26092 melanocyte .a 1723 to 2171 461 to 1       461/481
(95 %)
18 diff
(96.3 %id)
H99474 melanocyte .a 1737 to 2165 437 to 7   fully sequenced,   431/437
(98 %)
0 diff
(100 %id)
CN402436 embryonic stem cells, cell lines H1, H7, andH9 .a 1739 to 2152 414 to 1     Submitted on the opposite strand 414/414
(100 %)
2 diff
(99.6 %id)
N26146 melanocyte .a 1739 to 2171 433 to 1       433/433
(100 %)
2 diff
(99.6 %id)
N73282 melanocyte .a 1748 to 2172 431 to 1       431/431
(100 %)
6 diff
(98.7 %id)
ES309117 occipital hair of pubic hypotrichosispatient, skin .a 1756 to 2339 590 to 9   tiling clone, Submitted on the opposite strand 582/600
(97 %)
0 diff
(100 %id)
N27842 melanocyte .a 1761 to 2171 413 to 1       413/417
(99 %)
2 diff
(99.6 %id)
BF513010   .a 1770 to 2171 419 to 18   AAA   402/402
(100 %)
3 diff
(99.3 %id)
N80675 lung .a 1773 to 2172 403 to 1       403/403
(100 %)
4 diff
(99.1 %id)
EC477469 Prostate .a 1774 to 1860 85 to 1       85/96
(88 %)
2 diff
(98.0 %id)
AW628432 2 pooled high-grade transitional celltumors, genitourinary tract .a 1783 to 2171 410 to 22   AAA   389/389
(100 %)
4 diff
(99.0 %id)
AA405509   .a 1789 to 2175 388 to 2       387/388
(99 %)
0 diff
(100 %id)
AA386120 Pancreas .a 1814 to 2175 364 to 4     Submitted on the opposite strand 361/364
(99 %)
0 diff
(100 %id)
AA780124   .a 1820 to 2168 352 to 4       349/352
(99 %)
0 diff
(100 %id)
AW195989 adenocarcinoma, Pancreas .a 1841 to 2175 340 to 1       340/345
(98 %)
5 diff
(98.6 %id)
AW074713 colon, juvenile granulosa tumor .a 1842 to 2171 333 to 1       333/333
(100 %)
6 diff
(98.2 %id)
N26547 melanocyte .a 1849 to 2171 328 to 1       328/330
(99 %)
30 diff
(91.0 %id)
AA410443 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 1850 to 2285 437 to 1       437/437
(100 %)
1 diff
(99.8 %id)
AW069406 bone marrow stroma .a 1852 to 2171 345 to 26   AAA   320/320
(100 %)
0 diff
(100 %id)
AI699775 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 1868 to 2172 305 to 1       305/314
(97 %)
0 diff
(100 %id)
R25189 placenta .a 1928 to 2172 251 to 1       251/293
(85 %)
9 diff
(97.0 %id)
N93672 lung .a 1986 to 2171 197 to 12   AAA   186/187
(99 %)
0 diff
(100 %id)
H61817 ovarian tumor, ovary .a 2035 to 2315 281 to 1       281/281
(100 %)
0 diff
(100 %id)
CD616201   .b 1 to 626 29 to 643   tiling clone,   615/643
(95 %)
20 diff
(96.9 %id)
DA548405   .b 196 to 717 2 to 528   capped   527/527
(100 %)
7 diff
(98.7 %id)
DA148172 amygdala .b 203 to 641 2 to 440   capped   439/439
(100 %)
2 diff
(99.6 %id)
DA651907   .b 203 to 758 2 to 559   capped   558/558
(100 %)
2 diff
(99.7 %id)
ES311147 scalp interfollicular dermis, skin .b 204 to 874 1 to 652       652/681
(95 %)
26 diff
(96.2 %id)
CN402433 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 205 to 744 12 to 551       540/551
(98 %)
8 diff
(98.6 %id)
CN483690 eye .b 205 to 669 1 to 466       466/466
(100 %)
4 diff
(99.2 %id)
BM803851 leiomyosarcoma, uterus .b 208 to 892 24 to 716       693/1122
(61 %)
15 diff
(98.7 %id)
CB215840 normal endometrium, late proliferativephase, cycle day 13, uterus .b 208 to 821 1 to 614       614/614
(100 %)
0 diff
(100 %id)
CN402437 embryonic stem cells, cell lines H1, H7, andH9 .b 210 to 909 5 to 704       700/704
(99 %)
6 diff
(99.2 %id)
DA553863   .b 212 to 783 2 to 574   capped   573/573
(100 %)
2 diff
(99.7 %id)
DA823889 pericardium .b 216 to 743 2 to 530   capped   529/529
(100 %)
2 diff
(99.7 %id)
DB267582 uterus .b 216 to 701 2 to 487   capped   486/486
(100 %)
0 diff
(100 %id)
DA998321   .b 220 to 779 2 to 561   capped   560/560
(100 %)
2 diff
(99.7 %id)
BE889112 leiomyosarcoma, uterus .b 222 to 974 1 to 743       743/749
(99 %)
15 diff
(98.0 %id)
CN402434 embryonic stem cells, cell lines H1, H7, andH9 .b 224 to 942 1 to 719       719/719
(100 %)
2 diff
(99.8 %id)
BE884732 leiomyosarcoma, uterus .b 227 to 957 1 to 733       733/923
(79 %)
21 diff
(97.8 %id)
BU146292 dorsal root ganglia .b 231 to 989 1 to 760   tiling clone,   760/929
(81 %)
6 diff
(99.4 %id)
BF127414 leiomyosarcoma cell line, uterus .b 241 to 990 1 to 749       749/895
(83 %)
28 diff
(96.9 %id)
CX755123 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .b 245 to 969 1 to 720     Submitted on the opposite strand 720/838
(85 %)
7 diff
(99.2 %id)
CV023287 mixed .b 359 to 973 1 to 614       614/614
(100 %)
1 diff
(99.9 %id)
BI850102 moderate to poorly differentiated invasivecarcinoma of the retromolar trigone, mouth .b 363 to 627 21 to 285     Submitted on the opposite strand 265/316
(83 %)
7 diff
(97.8 %id)
BG825217 muscle, rhabdomyosarcoma .b 384 to 980 172 to 784       613/784
(78 %)
28 diff
(96.5 %id)
CF264758 Brain glioblastoma .b 541 to 1385 1 to 849   tiling clone,   849/858
(98 %)
11 diff
(98.8 %id)
BX506033   .b 883 to 1426 1 to 540   tiling clone,   540/541
(99 %)
12 diff
(97.8 %id)
BX480378   .b 2249 to 2668 438 to 18   tiling clone, AAA   421/421
(100 %)
1 diff
(99.8 %id)
DA457775 tongue, tumor tissue .c-u 1 to 563 2 to 564 exact tiling clone, capped   563/563
(100 %)
0 diff
(100 %id)
DB358478 whole embryo, mainly head Gene SNAI2, variant not shown         Suspected internal deletion, this clone was ignored    
DA571608 whole embryo, mainly head Gene SNAI2, variant not shown       capped Suspected internal deletion, this clone was ignored    
BP339522 Spleen Gene SNAI2, variant not shown         Suspected internal deletion, suspected internal deletion, this clone was ignored    
DB006761 cervix, tumor tissue Gene SNAI2, variant not shown       capped Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DC